Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

HLA associations with infliximab-induced liver injury.

Bruno CD, Fremd B, Church RJ, Daly AK, Aithal GP, Björnsson ES, Larrey D, Watkins PB, Chow CR.

Pharmacogenomics J. 2020 Feb 6. doi: 10.1038/s41397-020-0159-0. [Epub ahead of print]

PMID:
32024945
2.

Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.

Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V.

Liver Int. 2020 Jan 28. doi: 10.1111/liv.14393. [Epub ahead of print]

PMID:
31991029
3.

Acute lower gastrointestinal bleeding: A population-based five-year follow-up study.

Hreinsson JP, Ægisdottir S, Bjornsson ES.

United European Gastroenterol J. 2019 Dec;7(10):1330-1336. doi: 10.1177/2050640619863517. Epub 2019 Jul 8.

4.

[Gastrointestinal bleeding in Iceland and in broader terms - a review].

Hreinsson JP, Bjornsson ES.

Laeknabladid. 2019 Dec;105(12):563-569. doi: 10.17992/lbl.2019.12.262. Icelandic.

5.

Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury.

Björnsson ES.

Clin Liver Dis. 2020 Feb;24(1):1-10. doi: 10.1016/j.cld.2019.08.002. Epub 2019 Oct 28. Review.

PMID:
31753242
6.

Problems Associated with Deprescribing of Proton Pump Inhibitors.

Helgadottir H, Bjornsson ES.

Int J Mol Sci. 2019 Nov 2;20(21). pii: E5469. doi: 10.3390/ijms20215469. Review.

7.

Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood.

Olafsson S, Alexandersson KF, Gizurarson JGK, Hauksdottir K, Gunnarsson O, Olafsson K, Gudmundsson J, Stacey SN, Sveinbjornsson G, Saemundsdottir J, Bjornsson ES, Olafsson S, Bjornsson S, Orvar KB, Vikingsson A, Geirsson AJ, Arinbjarnarson S, Bjornsdottir G, Thorgeirsson TE, Sigurdsson S, Halldorsson GH, Magnusson OT, Masson G, Holm H, Jonsdottir I, Sigurdardottir O, Eyjolfsson GI, Olafsson I, Sulem P, Thorsteinsdottir U, Jonsson T, Rafnar T, Gudbjartsson DF, Stefansson K.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):225-235. doi: 10.1158/1055-9965.EPI-18-1060. Epub 2019 Oct 30.

PMID:
31666285
8.

Drug-Induced Liver Injury - Types and Phenotypes. Reply.

Hoofnagle JH, Björnsson ES.

N Engl J Med. 2019 Oct 3;381(14):1396. doi: 10.1056/NEJMc1911063. No abstract available.

PMID:
31577895
9.

A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase.

Björnsson HK, Björnsson ES.

Scand J Gastroenterol. 2019 Sep;54(9):1155-1159. doi: 10.1080/00365521.2019.1657177. Epub 2019 Sep 3.

PMID:
31479284
10.

RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.

Devarbhavi H, Bjornsson ES.

Gastroenterology. 2019 Nov;157(5):1437-1438. doi: 10.1053/j.gastro.2019.06.045. Epub 2019 Aug 20. No abstract available.

PMID:
31442436
11.

Drug-induced liver injury.

Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP.

Nat Rev Dis Primers. 2019 Aug 22;5(1):58. doi: 10.1038/s41572-019-0105-0. Review.

PMID:
31439850
12.

Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs.

Valgeirsson KB, Hreinsson JP, Björnsson ES.

Liver Int. 2019 Dec;39(12):2341-2349. doi: 10.1111/liv.14224. Epub 2019 Aug 30.

PMID:
31436903
13.

Drug-Induced Liver Injury - Types and Phenotypes.

Hoofnagle JH, Björnsson ES.

N Engl J Med. 2019 Jul 18;381(3):264-273. doi: 10.1056/NEJMra1816149. Review. No abstract available.

PMID:
31314970
14.

Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study.

Örnolfsson KT, Lund SH, Olafsson S, Bergmann OM, Björnsson ES.

Scand J Gastroenterol. 2019 May;54(5):609-616. doi: 10.1080/00365521.2019.1606931. Epub 2019 May 10.

PMID:
31074667
15.

Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.

Nicoletti P, Barrett S, McEvoy L, Daly AK, Aithal G, Lucena MI, Andrade RJ, Wadelius M, Hallberg P, Stephens C, Bjornsson ES, Friedmann P, Kainu K, Laitinen T, Marson A, Molokhia M, Phillips E, Pichler W, Romano A, Shear N, Sills G, Tanno LK, Swale A, Floratos A, Shen Y, Nelson MR, Watkins PB, Daly MJ, Morris AP, Alfirevic A, Pirmohamed M.

Clin Pharmacol Ther. 2019 Nov;106(5):1028-1036. doi: 10.1002/cpt.1493. Epub 2019 Jul 3.

PMID:
31066027
16.

Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Helgadóttir H, Lund SH, Gizurarson S, Metz DC, Björnsson ES.

J Clin Gastroenterol. 2020 Mar;54(3):227-234. doi: 10.1097/MCG.0000000000001200.

PMID:
30994520
17.

EASL Clinical Practice Guidelines: Drug-induced liver injury.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:.

J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.

PMID:
30926241
18.

Risk factors for chronic and recurrent pancreatitis after first attack of acute pancreatitis.

Magnusdottir BA, Baldursdottir MB, Kalaitzakis E, Björnsson ES.

Scand J Gastroenterol. 2019 Jan;54(1):87-94. doi: 10.1080/00365521.2018.1550670. Epub 2019 Jan 31.

PMID:
30700163
19.

Long-Term Outcomes After Drug-Induced Liver Injury.

Hayashi PH, Bjornsson ES.

Curr Hepatol Rep. 2018 Sep;17(3):292-299. doi: 10.1007/s11901-018-0411-0. Epub 2018 Jul 2.

20.

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.

Cirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, Fontana RJ, Hallberg P, Li YJ, Lucena MI, Long N, Molokhia M, Nelson MR, Odin JA, Pirmohamed M, Rafnar T, Serrano J, Stefánsson K, Stolz A, Daly AK, Aithal GP, Watkins PB; Drug-Induced Liver Injury Network (DILIN) investigators; International DILI consortium (iDILIC).

Gastroenterology. 2019 May;156(6):1707-1716.e2. doi: 10.1053/j.gastro.2019.01.034. Epub 2019 Jan 18.

PMID:
30664875

Supplemental Content

Loading ...
Support Center